Northwest Arkansas Treatment Center First Site Initiated in Global Research on Ovarian Cancer
Highlands Oncology Group Will Collaborate To Research Immunotherapy For Ovarian Cancer
Rogers, AR, May 20, 2016 (Newswire.com)
Highlands Oncology Group (Highlands), Northwest Arkansas’ leading cancer research group, is at the forefront of ovarian cancer treatment research and breakthroughs. Highlands is proud to be the first site in the world initiated in a global study on the value of immunotherapy in ovarian cancer patients.
The study will explore the value of “anti-PDL-1” immunotherapy, in concurrence with chemotherapy, in the treatment of patients with targeted ovarian cancer. Highlands was was involved in the first phase of the trial.
Immunotherapy is treatment that uses certain parts of a person’s immune system to fight diseases such as cancer, according to the American Cancer Society (ACS). Ways this can be achieved include stimulating one's own immune system to work harder or smarter to attack cancer cells and providing immune system components, such as man-made immune system proteins, according to the ACS.
Ovarian cancer is the 11th most common cancer among women and the fifth leading cause of cancer related death among women, according to the Ovarian Cancer National Alliance. A woman’s lifetime risk of developing invasive ovarian cancer is one in 75. As ovarian cancer is the deadliest among the gynecologic cancers and continues to devastate the health of many women, continued research on the treatment of ovarian cancer is essential.
As the leading cancer treatment and research facility in Northwest Arkansas, Highlands is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.
The study is part of a global initiative to improve cancer care for those fighting the disease.
Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.
For more information visit www.HighlandsOncologyGroup.com.
Source: The Artist Evolution